X
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED, with a corresponding application number 2470268 and regulatory information .
proudly manufactured in the
Novo Nordisk's REBINYN POWDER FOR SOLUTION, medication with 1000UNIT/VIAL of COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED.